Exagen Stock Quote XGN - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.17

Bid

2.97

Ask

4.50

Volume

51,598

3.05 Day's Range 3.31

1.3003 52 Week Range 6.21

Market Cap

55.91M

Previous Close

3.29

Open

3.27

Last Trade

3.32

Last Trade Time

Financial Volume

$ 163,152

VWAP

3.162

Average Volume (3m)

119,573

Shares Outstanding

17,637,278

Dividend Yield

PE Ratio

-2.35

Earnings Per Share (EPS)

-1.34

Revenue

52.55M

Net Profit

-23.69M

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differentia... Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists. Show more

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

www.exagen.com

Headquarters

Wilmington, Delaware, USA

Founded

Exagen Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker XGN. The last closing price for Exagen was $3.29. Over the last year, Exagen shares have traded in a share price range of $ 1.3003 to $ 6.21.

Exagen currently has 17,637,278 shares outstanding. The market capitalization of Exagen is $58.03 million. Exagen has a price to earnings ratio (PE ratio) of -2.35.

Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results

New biomarkers on track for commercial launch in January 2025 Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD

CARLSBAD, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the completion of its 1,000,000th AVISE CTD test, marking a significant...

Form 4 - Statement of changes in beneficial ownership of securities

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform

CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the validation and regulatory submission for approval of new Systemic...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.064	2.0605280103	3.106	3.98	3	200889	3.46974133	CS
4	-2.8065	-46.9589224462	5.9765	6.19	3	193982	4.34835724	CS
12	0.39	14.0287769784	2.78	6.21	2.38	119573	4.37702043	CS
26	1.28	67.7248677249	1.89	6.21	1.78	81683	3.82672768	CS
52	1.08	51.6746411483	2.09	6.21	1.3003	60570	3.1930574	CS
156	-7.82	-71.1555959964	10.99	10.99	1.3003	47032	3.69830765	CS
260	-21.05	-86.91164327	24.22	27	1.3003	47144	8.36659285	CS

XGN - Frequently Asked Questions (FAQ)

What is the current Exagen share price?

The current share price of Exagen is $ 3.17

How many Exagen shares are in issue?

Exagen has 17,637,278 shares in issue

What is the market cap of Exagen?

The market capitalisation of Exagen is USD 58.03M

What is the 1 year trading range for Exagen share price?

Exagen has traded in the range of $ 1.3003 to $ 6.21 during the past year

What is the PE ratio of Exagen?

The price to earnings ratio of Exagen is -2.35

What is the cash to sales ratio of Exagen?

The cash to sales ratio of Exagen is 1.06

What is the reporting currency for Exagen?

Exagen reports financial results in USD

What is the latest annual turnover for Exagen?

The latest annual turnover of Exagen is USD 52.55M

What is the latest annual profit for Exagen?

The latest annual profit of Exagen is USD -23.69M

What is the registered address of Exagen?

The registered address for Exagen is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Exagen website address?

The website address for Exagen is www.exagen.com

Which industry sector does Exagen operate in?

Exagen operates in the MEDICAL LABORATORIES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VRMEVerifyMe Inc	$ 2.57 (52.98%)	57.83M
WKEYWISeKey International Holdings AG	$ 10.041 (52.83%)	6.72M
DATSDatChat Inc	$ 4.8105 (49.86%)	158.65M
CDTConduit Pharmaceuticals Inc	$ 0.1214 (48.05%)	1.17B
INTZIntrusion Inc	$ 2.8888 (44.44%)	40.61M
IGMSIGM Biosciences Inc	$ 2.095 (-66.21%)	5.69M
CDTGCDT Environmental Technology Investment Holdings Ltd	$ 1.87 (-51.30%)	2.28M
MODVModivCare Inc	$ 6.51 (-47.88%)	2.73M
AIFUAIX Inc	$ 0.420501 (-47.76%)	7.83M
MRSNMersana Therapeutics Inc	$ 0.691 (-46.85%)	58.31M
CDTConduit Pharmaceuticals Inc	$ 0.1214 (48.05%)	1.16B
NVDANVIDIA Corporation	$ 135.91 (-3.00%)	203.27M
RGTIRigetti Computing Inc	$ 8.9299 (-11.06%)	175.21M
VMARVision Marine Technologies Inc	$ 2.14 (40.79%)	174.99M
DATSDatChat Inc	$ 4.8105 (49.86%)	158.56M